Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
SECTOR GAMMA AS (CIK 1475373) reported $423.5M across 42 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: BMY ($50.2M, 11.86%), MRK ($31.3M, 7.39%), PFE ($30.6M, 7.24%), MDT ($24.3M, 5.74%), INCY ($18.9M, 4.46%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | BMY | BRISTOL-MYERS SQUIBB CO | $50.2M | 11.86% | 827,901 | Added |
| 2 | MRK | MERCK & CO INC | $31.3M | 7.39% | 260,340 | Trimmed |
| 3 | PFE | PFIZER INC | $30.6M | 7.24% | 1.1M | Added |
| 4 | MDT | MEDTRONIC PLC | $24.3M | 5.74% | 280,682 | Added |
| 5 | INCY | INCYTE CORP | $18.9M | 4.46% | 200,510 | Trimmed |
| 6 | AMGN | AMGEN INC | $16.6M | 3.92% | 47,155 | Trimmed |
| 7 | BIIB | BIOGEN INC | $16.5M | 3.90% | 90,096 | Added |
| 8 | ZBH | ZIMMER BIOMET HOLDINGS INC | $14.1M | 3.33% | 155,835 | Added |
| 9 | BMRN | BIOMARIN PHARMACEUTICAL INC | $13.6M | 3.20% | 239,918 | Added |
| 10 | BDX | BECTON DICKINSON & CO | $13.0M | 3.07% | 82,615 | Trimmed |
| 11 | ELV | ELEVANCE HEALTH INC FORMERLY | $12.9M | 3.04% | 43,962 | Added |
| 12 | IONS | IONIS PHARMACEUTICALS INC | $12.7M | 3.00% | 169,468 | Trimmed |
| 13 | CAH | CARDINAL HEALTH INC | $11.6M | 2.74% | 54,897 | Trimmed |
| 14 | UNH | UNITEDHEALTH GROUP INC | $9.9M | 2.33% | 36,435 | New |
| 15 | CVS | CVS HEALTH CORP | $9.7M | 2.30% | 135,337 | Trimmed |
| 16 | BRKR | BRUKER CORP | $9.2M | 2.17% | 254,010 | Trimmed |
| 17 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $9.0M | 2.12% | 126,418 | Added |
| 18 | ABT | ABBOTT LABS | $9.0M | 2.12% | 87,532 | New |
| 19 | GILD | GILEAD SCIENCES INC | $7.4M | 1.75% | 53,247 | Trimmed |
| 20 | LNTH | LANTHEUS HLDGS INC | $7.1M | 1.67% | 93,344 | Trimmed |
| 21 | IQV | IQVIA HLDGS INC | $6.9M | 1.62% | 40,230 | New |
| 22 | SNDX | SYNDAX PHARMACEUTICALS INC | $6.7M | 1.58% | 286,007 | Added |
| 23 | BIO | BIO RAD LABS INC | $6.6M | 1.56% | 23,750 | Hold |
| 24 | QGEN | QIAGEN NV | $6.5M | 1.54% | 162,371 | New |
| 25 | AVTR | AVANTOR INC | $5.5M | 1.29% | 695,403 | Hold |
Source: SEC Form 13F filings · as of 2026-03-31